Rallybio Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RLYB | ACTI.ST | JSPR | CLYM | XBIT | INMB | |
|---|---|---|---|---|---|---|
| Market cap | 85.60M | 101.09M | 17.01M | 535.88M | 59.45M | 41.18M |
| P/E (TTM) | 3.4 | — | — | — | — | — |
| Forward P/E | -2.9 | — | -0.7 | -9.3 | 15.0 | -3.1 |
| Price/book | 0.9 | 2.7 | 10.2 | 2.2 | 0.5 | 1.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +217.20% | −42.74% | −75.38% | +407.81% | −6.13% | −18.40% |
| Today | +0.25% | +4.21% | +6.48% | −4.31% | −2.01% | +0.76% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All RLYB news ›Head-To-Head Comparison: CRISPR Therapeutics (NASDAQ:CRSP) vs. Rallybio (NASDAQ:RLYB)
Posted by Tristan Rich on Nov 4th, 2026 CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) and Rallybio (NASDAQ:RLYB – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses…
Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
FinancialContent Former Attorney General of Louisiana Charles C and the law firm of Kahn Swick & Foti, LLC (âÂÂKSFâÂÂ) are investigating the proposed merger of Rallybio Corporation (NasdaqCM: RL
[EFFECT] Rallybio Corp SEC Filing
Rallybio Corp SEC Filing (Oct 16, 2026) Stock Titan [EFFECT] Rallybio Corp SEC Filing Sentiment and the balance of points Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The…
Rallybio director exercises options for 14,820 shares
Exercise prices ranged from $2.38 to $15.28 per share on October 12, 2026; the 9,196-share option was issued in lieu of $51,500 in retainer fees. Rallybio director exercises options for 14,820 shares A Rallybio director's exercise spanned…
Rallybio CEO exercises options for 22,456 shares
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer BlackRock Capital Allocation Term Trust (BCAT) Announces Results of its Rights Offering Healthcare Triangle, Inc. Announces 1-for-20…
Rallybio CFO Lieber exercises options for 3,910 shares
Jonathan I. Lieber held 13,650 common shares after the October 9, 2026 exercise; his reported remaining option position was zero shares. Rallybio CFO Lieber exercises options for 3,910 shares The option award is scheduled to vest in 48…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net4
- markets.financialcontent.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.